Dear Reader ,
Here is your customized PHYSorg.com Newsletter for August 29, 2010:
Spotlight Stories Headlines
- First genetic link to common migraine exposed- Vulnerability in commercial quanto cryptography
- Volcano quiet for 400 years erupts in Indonesia
- PR firm staff wrote iTunes 'customer' reviews
- Patent suits filed against Facebook, Apple, Google
- Study points to key genetic driver of severe allergic asthma
- Core knowledge of tree fruit expands with apple genome sequencing
- All genes in one go
- Neuronal diversity makes a difference, study says
- Location determines social network influence, study finds
- Study: More omega-3 fats didn't aid heart patients
Space & Earth news
Putin visits site of Russia's new launch center
(AP) -- Russia will launch its manned space missions from a new center in the Far East in 2018, Prime Minister Vladimir Putin said Saturday, as the country seeks greater independence for its space program.
Salvage operation could offer up clues to US oil spill
Efforts this weekend to salvage BP's blowout preventer could bring to the surface a key piece of evidence in the inquiry into the largest maritime oil spill in history.
Fertilizer chemicals linked to animal developmental woes
Fertilizer chemicals may pose a bigger hazard to the environment - specifically to creatures that live in water - than originally foreseen, according to new research from North Carolina State University toxicologists.
Volcano quiet for 400 years erupts in Indonesia
(AP) -- A volcano in western Indonesia spewed hot lava and sand high into the sky early Sunday in its first eruption in 400 years.
Technology news
ORNL graphite foam technology licensed to LED North America
Technology developed at the Department of Energy's Oak Ridge National Laboratory that extends the life of light-emitting diode lamps has been licensed to LED North America.
Emmy Awards go digital with Twitter, Facebook, YouTube
The 2010 Emmy Awards for American television have gone interactive, with viewers tweeting lines for host Jimmy Fallon, voting on an interactive ballot and watching backstage happenings on Facebook and YouTube.
Disney, Time Warner make progress on program fees
(AP) -- Walt Disney Co. and Time Warner Cable Inc. said Sunday that they have made "significant progress" in resolving their issues over programming fees with less than a week left to renew a pact that feeds TV channels like ESPN into American households.
Facebook sued in California over teen endorsements
(AP) -- Two Los Angeles County teenagers are suing Facebook, claiming the social network effectively sold their names and images to advertisers without parental permission.
PC industry's woes could mean bargains this fall
(AP) -- If you're looking for bargains on personal computers, bad news from the industry could be good for your pocketbook.
Internet Age overhaul of USA Today to cost jobs
USA Today on Friday announced a major restructuring that will trim 130 jobs at the national news publication as it reshapes itself to better fit Internet Age lifestyles.
3Par calls HP $30 bid 'superior'; Dell mulls reply
(AP) -- Data storage company 3Par Inc. says its board has determined that Hewlett-Packard Co.'s $2 billion, $30-per-share takeover bid is superior to a rival offer from Dell Inc., but Dell said Saturday it was mulling over a higher bid.
US chipset giant Qualcomm mulls Taiwan R&D unit: report
Qualcomm, the world's leading 3G mobile phone chipset supplier, plans to set up a research and development centre in Taiwan to help it tap China's growing market, a report said Sunday.
India BlackBerry users hold breath over ban
India's BlackBerry users are holding their breath as they wait to see if the government carries out a threat this week to ban encrypted messages sent on the phones due to fears of misuse by militants.
Hackers attack Philippine government website
The Philippines on Sunday ordered all government offices to tighten Internet security after its main information website was brought down by hackers.
Patent suits filed against Facebook, Apple, Google
A company owned by Microsoft co-founder Paul Allen on Friday blasted Apple, Facebook, Google, YouTube, Yahoo! and others with a patent infringement lawsuit filed in a US court.
PR firm staff wrote iTunes 'customer' reviews
US regulators have said a public relations firm has agreed to settle charges that it had employees pose as unbiased videogame buyers and post reviews at Apple's online iTunes store.
Medicine & Health news
Schizophrenia and psychotic syndromes
Schizophrenia and related psychotic disorders are a chronic and often disabling condition. Despite modern treatment techniques they still present an enormous burden to the patients and their relatives and take a serious toll in terms of human suffering and societal expenditure.
Developmental gene-environment interactions: A model for psychosis
The incidence of psychotic disorders varies greatly across places and demographic groups, as do symptoms, course, and treatment response across individuals. High rates of schizophrenia in large cities, and among immigrants, cannabis users, and traumatised individuals reflect the causal influence of environmental exposures. This, in combination with progress in the area of molecular genetics, has generated interest in more complicated models of schizophrenia aetiology that explicitly posit gene-environment interactions.
Genetic variation in key cell pumping mechanism reduces effects of clopidogrel treatment
A study published Online First and in an upcoming Lancet shows that patients with a genetic variation affecting a key protein pump in drug transport do not respond as well to the anticlotting drug clopidogrel—as such, patients with this variation at are at increased risk of cardiovascular events with standard clopidogrel treatment. However, no association exists between this genetic variation and another anticlotting drug, prasugrel.
Ticagrelor is better than clopidogrel to prevent blood clots regardless of genetic profile
A study published Online First and in an upcoming Lancet shows that anticlotting treatment using ticagrelor is better than clopidogrel, regardless of the presence of genetic variations that leads to variable efficacy of clopidogrel. Thus use of ticagrelor in patients with acute coronary syndromes eliminates the need for genetic testing that is considered necessary to avoid a poor response when treating with clopidogrel. The Article is written by Professor Lars Wallentin, Uppsala University, Sweden, and colleagues.
Study shows local standards of care affect the benefits of switching to new treatement alternatives
An analysis of a trial into how a new drug dabigatran was effective in preventing stroke in patients with atrial fibrillation has shown that local standards of care affect the benefits of switching to new treatments. This analysis of the RELY trial is reported in an Article Online First and in an upcoming Lancet, and is being presented at this week's European Society of Cardiology meeting in Stockholm, Sweden. The Article is by Professor Lars Wallentin, Uppsala University, Sweden, and colleagues.
CEO: J&J let down public, must work to build trust
(AP) -- With Johnson & Johnson's once-golden reputation tarnished by 11 recalls of medicines, contact lenses and hip implants in as many months, its chief executive says he knows the company let consumers down.
Admin. official: FDA to inspect large egg farms
(AP) -- The Food and Drug Administration is planning to inspect all of the country's largest egg farms before the end of next year following the massive recall of tainted eggs linked to a salmonella outbreak that has sickened as many as 1,500 people.
Medicare expands coverage to help smokers quit
(AP) -- Even though they've lived with the health warnings much of their lives and doubtless seen the ill effects on friends, relatives and even themselves, about 4.5 million older Americans continue to smoke.
Appeals court rejects autism vaccine link
(AP) -- A federal appeals court on Friday upheld a ruling that vaccines are not to blame for autism.
Encephalitis kills 215 in India, toll expected to soar
At least 215 people, mostly children, have died in an outbreak of Japanese encephalitis in an impoverished region of northern Indian and the death toll is likely to soar, officials said Saturday.
Study contradicts reports of problems with blood-thinner
New findings by McMaster University researchers contradict earlier reports that people with a certain genetic make-up don't benefit from the blood-thinner clopidogrel, also known as Plavix.
Neuronal diversity makes a difference, study says
Much like snowflakes, no two neurons are exactly alike. But it's not the size or shape that sets one neuron apart from another, it's the way it responds to incoming stimuli. Carnegie Mellon University researchers have discovered that this diversity is critical to overall brain function and essential in how neurons process complex stimuli and code information. The researchers published their findings, the first to examine the function of neuron diversity, online in Nature Neuroscience.
All genes in one go
The majority of rare diseases are hereditary. But despite significant progress in genome research, in most cases their exact cause remains unclear. The discovery of the underlying genetic defect is, however, a prerequisite for their definitive diagnosis and the development of innovative approaches to their treatment.
Study points to key genetic driver of severe allergic asthma
Scientists have identified a genetic basis for determining the severity of allergic asthma in experimental models of the disease.
Study: More omega-3 fats didn't aid heart patients
(AP) -- Eating more heart-healthy omega-3 fats provided no additional benefit in a study of heart attack survivors who were already getting good care, Dutch researchers report.
First genetic link to common migraine exposed
A world-wide collaboration of researchers has identified the first-ever genetic risk factor associated with common types of migraine. The researchers, who looked at the genetic data of more than 50,000 people, have produced new insights into the triggers for migraines attacks and they hope their research will open the door for novel therapeutics to prevent migraine attacks.
Biology news
Sanofi-Aventis makes 18.5 bln dollar bid for US Genzyme
French pharmaceutical group Sanofi-Aventis unveiled Sunday an 18.5 billion dollar (14.5 billion euro) offer for US biotechnology firm Genzyme, hinting it may launch a hostile bid.
Core knowledge of tree fruit expands with apple genome sequencing
An international team of scientists from Italy, France, New Zealand, Belgium and the USA have published a draft sequence of the domestic apple genome in the current issue of Nature Genetics.
This email is a free service of PhysOrg.com
You received this email because you subscribed to our list.
If you no longer want to receive this email use the link below to unsubscribe.
http://www.physorg.com/profile/nwletter/
You are subscribed as mail@joashmabs.com
No comments:
Post a Comment